Lava Therapeutics raised €70M in a Series C round in Sep 2020. The company is based in Utrecht, Netherlands. Investors in the round: Novo Ventures, Sanofi Ventures. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
